XML 66 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based compensation expense - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Shares    
Beginning balance (in shares) 2,453,000  
Granted (in shares) 0  
Forfeited (in shares) (37,000)  
Exercised (in shares) (35,000)  
Ending balance (in shares) 2,381,000 2,453,000
Number of options, Nonvested at December 31, 2022 (in shares) 427,000  
Number of options, Exercisable (in shares) 1,954,000  
Weighted average exercise price per share    
Beginning balance (in usd per share) $ 24.67  
Granted (in usd per share) 0  
Forfeited (in usd per share) 42.87  
Exercised (in dollars per share) 17.17  
Ending balance (in usd per share) 24.49 $ 24.67
Weighted average exercise price per share, Nonvested at December 31, 2022 (in dollars per share) 33.87  
Vested and exercisable (in usd per share) $ 22.44  
Weighted average remaining contractual term (years)    
Outstanding 6 years 21 days 6 years 3 months 29 days
Weighted average remaining contractual term (years), Nonvested at December 31, 2022 6 years 11 months 1 day  
Weighted average remaining contractual term (years), Exercisable 5 years 10 months 13 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding beginning balance $ 33,447  
Exercised 312  
Aggregate intrinsic value, outstanding ending balance 10,715 $ 33,447
Aggregate intrinsic value, nonvested 423  
Aggregate intrinsic value, Vested and exercisable $ 10,292  
Performance Stock Options    
Shares    
Beginning balance (in shares) 312,000  
Vested (in shares) (237,000)  
Ending balance (in shares) 312,000 312,000
Number of options, Nonvested at December 31, 2022 (in shares) 56,000 293,000
Number of options, Exercisable (in shares) 256,000 19,000
Weighted average exercise price per share    
Beginning balance (in usd per share) $ 61.35  
Vested (in usd per share) 70.84  
Ending balance (in usd per share) 61.35 $ 61.35
Weighted average exercise price per share, Nonvested at December 31, 2022 (in dollars per share) 31.29 63.27
Vested and exercisable (in usd per share) $ 67.95 $ 31.29
Weighted average remaining contractual term (years)    
Outstanding 8 years 29 days 8 years 3 months 29 days
Weighted average remaining contractual term (years), Nonvested at December 31, 2022 9 years 3 months 25 days 8 years 3 months
Weighted average remaining contractual term (years), Exercisable 7 years 9 months 21 days 9 years 6 months 25 days
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding beginning balance $ 296  
Aggregate intrinsic value, outstanding ending balance   $ 296
Aggregate intrinsic value, nonvested   222
Aggregate intrinsic value, Vested and exercisable   $ 74